Investigating how immune cells contribute to eye damage in diabetes
Cell-Meditated Inflammatory Pathway and Diabetic Retinopathy
This study is looking at how certain immune cells in the eye might cause damage to important cells that help keep blood vessels healthy, which could lead to vision problems for people with diabetes, and the researchers hope to find new ways to prevent or treat this issue.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Rio Grande Valley NIH-funded |
| Lab location | 1 site (Edinburg, United States) |
| Project ID | NIH-10368669 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of immune cells, specifically macrophages, in the loss of retinal pericytes, which are crucial for maintaining healthy blood vessels in the eye. The study aims to explore how these immune cells secrete a protein called TGFβ1 that may lead to the death of retinal pericytes, contributing to diabetic retinopathy. By examining the interactions between these immune cells and retinal cells, the researchers hope to identify potential biomarkers and therapeutic targets that could help prevent or treat this condition in diabetic patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetes who are at risk of developing diabetic retinopathy.
Not a fit: Patients without diabetes or those who do not have any signs of diabetic retinopathy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent or slow the progression of diabetic retinopathy, potentially preserving vision for patients with diabetes.
How similar studies have performed: Previous research has shown promising results in understanding the role of immune cells in other forms of diabetic complications, suggesting that this approach may yield valuable insights.
Where this research is happening
Edinburg, United States
- University of Texas Rio Grande Valley — Edinburg, United States (Active)
Researchers
- Principal investigator: Tsin, Andrew T C — University of Texas Rio Grande Valley
- Study coordinator: Tsin, Andrew T C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.